These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 10398436
1. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma. Bläker H, Hofmann WJ, Rieker RJ, Penzel R, Graf M, Otto HF. Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436 [Abstract] [Full Text] [Related]
2. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient. Inukai T, Furuuchi K, Sugita K, Uno K, Ooi A, Sasaki F, Hamada J, Moriuchi T, Nakazawa S. Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913 [Abstract] [Full Text] [Related]
3. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. Cancer Res; 1999 Jan 15; 59(2):269-73. PubMed ID: 9927029 [Abstract] [Full Text] [Related]
4. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. Oncogene; 2000 Jan 27; 19(4):498-504. PubMed ID: 10698519 [Abstract] [Full Text] [Related]
5. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, Ozaki T, Furuuchi K, Tada M, Ohnuma N, Nakagawara A. Clin Cancer Res; 2001 Apr 27; 7(4):901-8. PubMed ID: 11309340 [Abstract] [Full Text] [Related]
6. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T. J Pathol; 2004 Dec 27; 204(5):546-54. PubMed ID: 15538750 [Abstract] [Full Text] [Related]
7. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Am J Pathol; 1997 Aug 27; 151(2):329-34. PubMed ID: 9250146 [Abstract] [Full Text] [Related]
8. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E. Oncol Rep; 2006 Mar 27; 15(3):551-6. PubMed ID: 16465411 [Abstract] [Full Text] [Related]
9. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Anna CH, Sills RC, Foley JF, Stockton PS, Ton TV, Devereux TR. Cancer Res; 2000 Jun 01; 60(11):2864-8. PubMed ID: 10850429 [Abstract] [Full Text] [Related]
10. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients. Müller O, Nimmrich I, Finke U, Friedl W, Hoffmann I. Genes Chromosomes Cancer; 1998 May 01; 22(1):37-41. PubMed ID: 9591632 [Abstract] [Full Text] [Related]
11. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Cancer Res; 1998 Mar 15; 58(6):1130-4. PubMed ID: 9515795 [Abstract] [Full Text] [Related]
12. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Bläker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, Helmke BM. Genes Chromosomes Cancer; 2004 Oct 15; 41(2):93-8. PubMed ID: 15287021 [Abstract] [Full Text] [Related]
13. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. Nat Genet; 2000 Mar 15; 24(3):245-50. PubMed ID: 10700176 [Abstract] [Full Text] [Related]
14. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426 [Abstract] [Full Text] [Related]
15. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Cagatay T, Ozturk M. Oncogene; 2002 Nov 14; 21(52):7971-80. PubMed ID: 12439747 [Abstract] [Full Text] [Related]
16. APC truncation and increased beta-catenin levels in a human breast cancer cell line. Schlosshauer PW, Brown SA, Eisinger K, Yan Q, Guglielminetti ER, Parsons R, Ellenson LH, Kitajewski J. Carcinogenesis; 2000 Jul 14; 21(7):1453-6. PubMed ID: 10874025 [Abstract] [Full Text] [Related]
17. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. Xu B, Yoshimoto K, Miyauchi A, Kuma S, Mizusawa N, Hirokawa M, Sano T. J Pathol; 2003 Jan 14; 199(1):58-67. PubMed ID: 12474227 [Abstract] [Full Text] [Related]
18. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL. J Pathol; 2001 May 14; 194(1):20-6. PubMed ID: 11329137 [Abstract] [Full Text] [Related]
19. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Int J Oncol; 2002 May 14; 20(5):905-11. PubMed ID: 11956582 [Abstract] [Full Text] [Related]
20. Somatic mutations of the APC gene in sporadic hepatoblastomas. Oda H, Imai Y, Nakatsuru Y, Hata J, Ishikawa T. Cancer Res; 1996 Jul 15; 56(14):3320-3. PubMed ID: 8764128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]